Oral melatonin versus nebulized dexmedetomidine to reduce emergence agitation after adenotonsillectomy in children
Official title: Comparison Between Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Prospective, Randomized Controlled Trial
Run by Tanta University · NCT07345715 · Data updated 2026-11-12
We will test whether giving oral melatonin or nebulized dexmedetomidine before anesthesia better prevents children aged 3–7 from becoming agitated as they wake after adenotonsillectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 7 Years |
| Sex | All |
| Enrollment | 96 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El-Gharbia) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07345715 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 3 to 7 years, ASA I–II, scheduled for elective adenotonsillectomy whose parents consent and who do not have the listed neurological, developmental, or medication exclusions are ideal candidates.
✕Probably not a fit
Children with developmental delays, central nervous system or psychiatric conditions, current or recent anticonvulsant or sedative use, or known hypersensitivity to melatonin, dexmedetomidine, or midazolam are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children aged 3–7 with ASA physical status I–II who are scheduled for elective adenotonsillectomy receive a preoperative dose of either oral melatonin, nebulized dexmedetomidine, or normal saline. Emergence agitation and postoperative pain are monitored in the immediate recovery period using standard clinical scales. Patients with developmental delay, central nervous system disorders, recent use of anticonvulsants or sedative medications, or known allergies to the study drugs are excluded. The trial compares the frequency and severity of emergence agitation between the intervention groups to determine which premedication strategy provides better wake-up behavior.
Why it matters
Potential benefit: If successful, the intervention could reduce the frequency and severity of emergence agitation and related postoperative discomfort in young children after adenotonsillectomy.
How similar studies have gone: Previous smaller trials have shown nebulized or intravenous dexmedetomidine can reduce emergence agitation and melatonin has shown promising effects, but direct head-to-head comparisons in this population are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged between 3 and 7 years. * Both sexes. * Classified as American Society of Anesthesiologists (ASA) physical status I or II according to the American Society of Anesthesiologists. * Scheduled for elective adenotonsillectomy under general anesthesia. Exclusion Criteria: * Parental refusal to participate in the study. * Known allergy or hypersensitivity to dexmedetomidine, melatonin or midazolam. * Presence of developmental delay. * Central nervous system disorders. * Intellectual disability (formerly termed mental retardation). * Neurological or psychiatric conditions associated with anxiety or agitation (e.g., cerebral palsy, epilepsy, separation anxiety disorder, attention-deficit/hyperactivity disorder). * Current or recent treatment with anticonvulsants or sedative medications
Where it's running
-
Tanta University
Tanta, El-Gharbia, Egypt Recruiting
Study contacts
- Study coordinator: Amany A Eid, MSc
- Email: amany.kamel@med.tanta.edu.eg
- Phone: 00201012301802
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lactium premedication to see if it prevents emergence agitation after adenotonsillectomy
A preoperative dose of Lactium is tested to see if it prevents emergence agitation in children after adenotonsillectomy.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Postoperative Pain After Pediatric Adenotonsillectomy: Ibuprofen Plus Tylenol vs Ketorolac Plus Tylenol
This observational study will see if teens (13-18) who have adenotonsillectomy and take acetaminophen with ibuprofen or acetaminophen with ketorolac after discharge experience different levels of pain and recovery.
-
Oral vs IV Magnesium for Emergence Delirium in Children after Adenotonsillectomy
This trial tests whether giving magnesium by mouth before surgery or by IV during surgery can reduce emergence delirium in children aged 4–7 undergoing adenotonsillectomy with sevoflurane anesthesia.
-
Intranasal dexmedetomidine versus oral midazolam for premedication in children having elective inguinal or urological surgery
This trial will test whether intranasal dexmedetomidine or oral midazolam works better to calm children aged 2–10 before elective inguinal or urological surgery.
-
Repeated verbal orientation reminders to reduce emergence agitation after general anesthesia
We'll try prerecorded verbal orientation reminders through headphones to see if they reduce wake-up agitation in adults (18–70) having elective laparoscopic abdominal surgery with sevoflurane general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.